Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children: a randomized, double-blind, placebo-controlled trial

Intermittent and episode-driven use of pranlukast to reduce the frequency of wheezing in atopic children: a randomized, double-blind, placebo-controlled trial

Background Leukotriene receptor antagonist (LTRA) therapy reduces asthma exacerbations in children older than 2 years. However, whether early intervention using LTRA in atopic smaller children aged 1 to 2 years who had experienced episodic wheezing can reduce the frequency of wheezing is unknown.Met...

Full description

Bibliographic Details
Main Authors: Motohiro Ebisawa, Akihiko Terada, Kazuki Sato, Fumitake Kurosaka, Naomi Kondo, Chizuko Sugizaki, Akihiro Morikawa, Sankei Nishima, Mitsuyoshi Urashima
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:World Allergy Organization Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S193945511930208X

Internet

http://www.sciencedirect.com/science/article/pii/S193945511930208X

Similar Items